B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor

Debra J. Post-Munson, Rick L. Pieschl, Thaddeus F. Molski, John D. Graef, Adam W. Hendricson, Ronald J. Knox, Ivar M. McDonald, Richard E. Olson, John E. Macor, Michael R. Weed, Linda J. Bristow, Laszlo Kiss, Michael K. Ahlijanian, James Herrington

Research output: Contribution to journalArticle

Abstract

The alpha7 (α7) nicotinic acetylcholine receptor is a therapeutic target for cognitive disorders. Here we describe 3-(3,4-difluorophenyl)-N-(1-(6-(4-(pyridin-2-yl)piperazin-1-yl)pyrazin-2-yl)ethyl)propanamide (B-973), a novel piperazine-containing molecule that acts as a positive allosteric modulator of the α7 receptor. We characterize the action of B-973 on the α7 receptor using electrophysiology and radioligand binding. At 0.1mM acetylcholine, 1μM B-973 potentiated peak acetylcholine-induced currents 6-fold relative to maximal acetylcholine (3mM) and slowed channel desensitization, resulting in a 6900-fold increase in charge transfer. The EC50 of B-973 was approximately 0.3μM at acetylcholine concentrations ranging from 0.03 to 3mM. At a concentration of 1μM, B-973 shifted the acetylcholine EC50 of peak currents from 0.30mM in control to 0.007mM. B-973 slowed channel deactivation upon acetylcholine removal (τ=50s) and increased the affinity of the α7 agonist [3H]A-585539. In the absence of exogenously added acetylcholine, application of B-973 at concentrations >1μM induced large methyllycaconitine-sensitive currents, suggesting B-973 can function as an Ago-PAM at high concentrations. B-973 will be a useful probe for investigating the biological consequences of increasing α7 receptor activity through allosteric modulation.

Original languageEnglish (US)
JournalEuropean Journal of Pharmacology
DOIs
StateAccepted/In press - Jul 20 2016
Externally publishedYes

Keywords

  • Allosteric modulation
  • Alzheimer's disease
  • Positive allosteric modulator
  • Schizophrenia
  • α7 Acetylcholine receptor

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor'. Together they form a unique fingerprint.

  • Cite this

    Post-Munson, D. J., Pieschl, R. L., Molski, T. F., Graef, J. D., Hendricson, A. W., Knox, R. J., McDonald, I. M., Olson, R. E., Macor, J. E., Weed, M. R., Bristow, L. J., Kiss, L., Ahlijanian, M. K., & Herrington, J. (Accepted/In press). B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2017.01.037